Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC
Conditions
- HIV Infection
- HIV Infections
Interventions
- DRUG: AZT+3TC+ABV (Trizivir)
- DRUG: Switching to LPV/r monotherapy (Kaletra)
Sponsor
Fundacion SEIMC-GESIDA
Collaborators